Neural Therapeutics Inc. (CSE:NURL)

Market Cap	1.69M
Revenue (ttm)	n/a
Net Income	-1.26M
EPS	-0.01
Shares Out	168.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,202
Average Volume	33,184
Open	0.0100
Previous Close	0.0150
Day's Range	0.0100 - 0.0100
52-Week Range	0.0100 - 0.0500
Beta	n/a
RSI	42.66
Earnings Date	Jun 25, 2026

About Neural Therapeutics

Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada. The company utilizes psychoactive plants, such as San Pedro, a cactus containing mescaline, for the creation of plant-based traditional medicine. Its products target substance use disorders, including alcohol and opioid dependence. The company was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: NURL